生化学試薬市場：製品タイプ別、エンドユーザー別-2025-2030年の世界予測

生化学試薬市場は、2023年に158億7,000万米ドルと評価され、2024年には168億5,000万米ドルに達すると予測され、CAGR 6.48%で成長し、2030年には246億4,000万米ドルに達すると予測されています。

生化学試薬生物科学研究および製造プロセスにおける化学反応を促進するために不可欠な多様な物質を構成します。様々な化学分析や実験に使用される物質として定義され、その範囲は医薬品、バイオテクノロジー、ライフサイエンスに及び、診断、医薬品開発、遺伝子工学において重要な役割を果たしています。生化学試薬の必要性は、分子生物学と個別化医療における加速度的な進歩によって強調されており、そこでは正確で効率的な生化学的アッセイが不可欠です。これらの試薬は、DNA配列決定、細胞培養、クロマトグラフィーなどの重要なプロセスで応用されており、最終用途は製薬、研究所、臨床診断、学術に及んでいます。主な成長要因としては、革新的な医薬品に対する需要の急増、バイオ医薬品分野の拡大、ライフサイエンス分野における研究費の増加などが挙げられます。さらに、慢性疾患や感染症の流行が増加していることから、生化学試薬を活用したより精密な診断ソリューションの需要が高まっています。新たなビジネスチャンスはバイオインフォマティクスとプロテオミクスにあり、そこでは高特異性試薬の開発がデータの精度と有効性に革命をもたらす可能性があります。このような機会を捉えるための調査には、試薬メーカーと先端研究ツール開発のためのハイテク企業との戦略的提携が含まれます。しかし、この市場は、厳しい規制の枠組み、先端試薬の高コスト、価格競争につながる競争の激化などの制約に直面しています。さらに、技術の陳腐化も大きな課題となっており、急速な進歩によって既存の試薬がすぐに使えなくなる可能性があります。技術革新は、特に合成生物学と個別化医療の分野において、試薬の精度と有用性を高めるためにAIと機械学習の統合に焦点を当てるべきです。市場は多様でありながら競争も激しく、課題の中でイノベーションを活用し成長を維持するためには、しっかりとした調査と戦略的な先見性が求められます。スケーラブルでコスト効率に優れ、多機能な試薬の合成に注力することで、企業はこの進化する環境において、より高い適応性と回復力を育むことができます。

市場力学：急速に進化する生化学試薬市場の主要市場インサイトを公開

生化学試薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 次世代遺伝子シーケンスおよびポリメラーゼ連鎖反応における生化学試薬の採用拡大
  • 慢性疾患の世界の増加
  • ヘルスケアおよびライフサイエンス分野における生化学試薬の応用拡大
• 市場抑制要因
  • 生化学試薬の開発に伴う高コスト
• 市場機会
  • 政府やバイオテクノロジー企業による生化学試薬の研究開発活動への取り組みや資金提供の増加
  • 薬剤の毒性を評価するための幹細胞研究の増加
• 市場の課題
  • 生化学試薬の開発承認に関する厳しい規制

ポーターの5つの力：生化学試薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、生化学試薬市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生化学試薬市場における外部からの影響の把握

外部マクロ環境要因は、生化学試薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生化学試薬市場における競合情勢の把握

生化学試薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生化学試薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生化学試薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生化学試薬市場における成功への道筋を描く

生化学試薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 次世代遺伝子配列解析およびポリメラーゼ連鎖反応における生化学試薬の採用拡大
    • 慢性疾患の発症率が世界的に上昇
    • ヘルスケア・ライフサイエンス分野における生化学試薬の応用拡大
  • 抑制要因
    • 生化学試薬の開発に伴う高コスト
  • 機会
    • 政府とバイオテクノロジー企業による生化学試薬の研究開発活動への取り組みと資金の増加
    • 薬剤の毒性を評価するための幹細胞調査の拡大
  • 課題
    • 生化学試薬の開発承認に関する厳格な規制
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 生化学試薬市場：製品タイプ別

• 細胞・組織培養試薬
• クロマトグラフィー試薬
• 電気泳動試薬
• ポリメラーゼ連鎖反応（PCR）試薬キット

第7章 生化学試薬市場：エンドユーザー別

• 学術と調査
• 契約調査機関（CRO）
• 診断センター
• 病院
• 製薬・バイオテクノロジー企業

第8章 南北アメリカの生化学試薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の生化学試薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの生化学試薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Alpha Teknova, Inc.
• AquaPhoenix Scientific, LLC.
• Becton, Dickinson and Company.
• Bio-Rad Laboratories, Inc.
• Bio-Techne Corporation
• bioMerieux, Inc.
• Biotron Diagnostics Inc.
• Danaher Corporation
• ERBA Diagnostics Mannheim
• Euroclone S.p.A.
• Genelinx International, Inc.
• LI-COR, Inc., d/b/a LI-COR Biosciences
• Lonza Group Ltd.
• Merck KGaA
• Promega Corporation
• ProteoChem, Inc.
• Quality Biological, Inc.
• Revvity, Inc.
• Siemens Healthineers AG
• Sysmex Asia Pacific Pte Ltd.
• Takara Bio USA, Inc.
• Thermo Fisher Scientific Inc.
• Viagen Biotech, Inc.
• Waters Corporation

LIST OF FIGURES

• FIGURE 1. BIOCHEMICAL REAGENTS MARKET RESEARCH PROCESS
• FIGURE 2. BIOCHEMICAL REAGENTS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. BIOCHEMICAL REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. BIOCHEMICAL REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOCHEMICAL REAGENTS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOCHEMICAL REAGENTS MARKET DYNAMICS
• TABLE 7. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CELL & TISSUE CULTURE REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CHROMATOGRAPHY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY ELECTROPHORESIS REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY POLYMERASE CHAIN REACTION (PCR) REAGENT KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY ACADEMICS & RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOCHEMICAL REAGENTS MARKET SIZE, BY PHARMA & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. CANADA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES BIOCHEMICAL REAGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. CHINA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CHINA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. INDIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. INDIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. ITALY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ITALY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. POLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. POLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. QATAR BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. QATAR BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM BIOCHEMICAL REAGENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM BIOCHEMICAL REAGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. BIOCHEMICAL REAGENTS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. BIOCHEMICAL REAGENTS MARKET, FPNV POSITIONING MATRIX, 2023

The Biochemical Reagents Market was valued at USD 15.87 billion in 2023, expected to reach USD 16.85 billion in 2024, and is projected to grow at a CAGR of 6.48%, to USD 24.64 billion by 2030.

Biochemical reagents constitute a diverse array of substances essential for facilitating chemical reactions in bioscientific research and manufacturing processes. Defined as substances used in various chemical analyses and experiments, their scope extends across pharmaceuticals, biotechnology, and life sciences, playing a critical role in diagnostics, drug development, and genetic engineering. The necessity of biochemical reagents is underscored by the accelerating advancements in molecular biology and personalized medicine, where accurate and efficient biochemical assays are indispensable. These reagents find application in critical processes such as DNA sequencing, cell culture, and chromatography, with end-use spanning pharmaceuticals, research labs, clinical diagnostics, and academia. Key growth influences encompass the surging demand for innovative drugs, the expansion of biopharmaceutical sectors, and rising research funding in life sciences. Additionally, the increasing prevalence of chronic and infectious diseases drives the demand for more precise diagnostic solutions utilizing biochemical reagents. Emerging opportunities lie in bioinformatics and proteomics, where the development of high-specificity reagents could revolutionize data accuracy and efficacy. Recommendations to seize such opportunities include strategic partnerships between reagent manufacturers and tech companies for advanced research tools development. However, this market faces limitations like stringent regulatory frameworks, high costs of advanced reagents, and heightened competition leading to price wars. Additionally, technological obsolescence poses significant challenges, where rapid advancements can outdate existing reagents quickly. Innovation should focus on the integration of AI and machine learning to enhance reagent precision and utility, particularly within synthetic biology and personalized medicine sectors. The market reveals a diverse yet highly competitive nature, requiring robust research and strategic foresight to leverage innovation and sustain growth amidst challenges. By focusing on the synthesis of scalable, cost-effective, and multifunctional reagents, companies can foster greater adaptability and resilience in this evolving landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biochemical Reagents Market

The Biochemical Reagents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
  • Rise in the incidences of chronic diseases globally
  • Expanding the application of biochemical reagents in the healthcare and life science sectors
• Market Restraints
  • High cost associated with the development of biochemical reagents
• Market Opportunities
  • Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
  • Growing stem cell research to assess the toxicity of medications
• Market Challenges
  • Strict regulations for the approval of the development of biochemical reagents

Porter's Five Forces: A Strategic Tool for Navigating the Biochemical Reagents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biochemical Reagents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biochemical Reagents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biochemical Reagents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biochemical Reagents Market

A detailed market share analysis in the Biochemical Reagents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biochemical Reagents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biochemical Reagents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biochemical Reagents Market

A strategic analysis of the Biochemical Reagents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biochemical Reagents Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Alpha Teknova, Inc., AquaPhoenix Scientific, LLC., Becton, Dickinson and Company., Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMerieux, Inc., Biotron Diagnostics Inc., Danaher Corporation, ERBA Diagnostics Mannheim, Euroclone S.p.A., Genelinx International, Inc., LI-COR, Inc., d/b/a LI-COR Biosciences, Lonza Group Ltd., Merck KGaA, Promega Corporation, ProteoChem, Inc., Quality Biological, Inc., Revvity, Inc., Siemens Healthineers AG, Sysmex Asia Pacific Pte Ltd., Takara Bio USA, Inc., Thermo Fisher Scientific Inc., Viagen Biotech, Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biochemical Reagents Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cell & Tissue Culture Reagents, Chromatography Reagents, Electrophoresis Reagents, and Polymerase Chain Reaction (PCR) Reagent Kits.
• Based on End-user, market is studied across Academics & Research, Contract Research Organizations (CROs), Diagnostic Centers, Hospitals, and Pharma & Biotech Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing adoption of biochemical reagents for next-generation gene sequencing and polymerase chain reaction
    • 5.1.1.2. Rise in the incidences of chronic diseases globally
    • 5.1.1.3. Expanding the application of biochemical reagents in the healthcare and life science sectors
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the development of biochemical reagents
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing initiatives and funding for research and development activities for biochemical reagents by the governments and biotechnological firms
    • 5.1.3.2. Growing stem cell research to assess the toxicity of medications
  • 5.1.4. Challenges
    • 5.1.4.1. Strict regulations for the approval of the development of biochemical reagents
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biochemical Reagents Market, by Product Type

• 6.1. Introduction
• 6.2. Cell & Tissue Culture Reagents
• 6.3. Chromatography Reagents
• 6.4. Electrophoresis Reagents
• 6.5. Polymerase Chain Reaction (PCR) Reagent Kits

7. Biochemical Reagents Market, by End-user

• 7.1. Introduction
• 7.2. Academics & Research
• 7.3. Contract Research Organizations (CROs)
• 7.4. Diagnostic Centers
• 7.5. Hospitals
• 7.6. Pharma & Biotech Companies

8. Americas Biochemical Reagents Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biochemical Reagents Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biochemical Reagents Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Alpha Teknova, Inc.
• 3. AquaPhoenix Scientific, LLC.
• 4. Becton, Dickinson and Company.
• 5. Bio-Rad Laboratories, Inc.
• 6. Bio-Techne Corporation
• 7. bioMerieux, Inc.
• 8. Biotron Diagnostics Inc.
• 9. Danaher Corporation
• 10. ERBA Diagnostics Mannheim
• 11. Euroclone S.p.A.
• 12. Genelinx International, Inc.
• 13. LI-COR, Inc., d/b/a LI-COR Biosciences
• 14. Lonza Group Ltd.
• 15. Merck KGaA
• 16. Promega Corporation
• 17. ProteoChem, Inc.
• 18. Quality Biological, Inc.
• 19. Revvity, Inc.
• 20. Siemens Healthineers AG
• 21. Sysmex Asia Pacific Pte Ltd.
• 22. Takara Bio USA, Inc.
• 23. Thermo Fisher Scientific Inc.
• 24. Viagen Biotech, Inc.
• 25. Waters Corporation